Closed · HT9425-23-PRCRP-CDA · CFDA 12.420 · Discretionary
DoD Peer Reviewed Cancer, Career Development Award
Federal grant opportunity posted by Defense Health Agency Contracting Activity - DHACA, cataloged on Grants.gov.
- Varies
- Award range
- Closed
- Status
- August 10, 2023
- Close date
- 12
- Expected awards
The verdict
DoD Peer Reviewed Cancer, Career Development Award is a closed discretionary listing from Defense Health Agency Contracting Activity - DHACA that offered Varies by applicant across 12 expected awards. Future funding cycles may be published under the same CFDA number. PlainGrants indexes 1,795 other opportunities from Defense Health Agency Contracting Activity - DHACA.
- Varies
- award range
- Closed
- application status
- 12
- expected awards
- 12.420
- CFDA program
Archived opportunity record
DoD Peer Reviewed Cancer is closed (last close August 10, 2023). Check the agency catalog for replacement NOFOs. Defense Health Agency Contracting Activity - DHACA still indexes 1,795 other opportunities here.
According to Grants.gov (extract vintage 2026-08-10), this record reflects the officially published listing. See methodology.
Deadline tracker
Application window closed
Closed August 10, 2023
Est. Total Funding
$76,800,000
Expected Awards
12
Instrument
Grant
Description
The PRCRP is seeking to advance cancer research through development of early-career investigators. Depending on the career path of the candidates, the PRCRP will offer two distinct early-career development options: the Career Development Award-Fellow Option (CDA-FO) and the Career Development Award-Resident Option (CDA-RO). Under this award mechanism, the early-career investigator is considered the Principal Investigator (PI), and the application should focus on the PI’s research and career development. The Career Development Award – Virtual Cancer Center Scholar Option is not being offered this fiscal year. Logical reasoning and a sound scientific rationale for the proposed research must be demonstrated. Preliminary data are not required. This award supports impactful research projects with an emphasis on discovery. · Fellow Option: The PI must be an early-career researcher or physician-scientist (referred to as a Fellow) within 7 years after completion of their terminal degree by the time of the application deadline (excluding time spent in residency, clinical training, or on family medical leave). PIs suitable for the Fellow Option include investigators who may not be on a tenure track and may share laboratory space not completely separate from a more established investigator. The intention of the Fellow Option is to support the early-career investigators toward wider independence and success. One research funding level is available for the Fellow Option. · Resident Option: The PI must be an early-career clinician during the time of their residency. PIs suitable for the Resident Option include investigators interested in a career path toward becoming a physician-scientist. The intention of the Resident Option is to support the early-career investigators research development with strong scientific career development. Two research funding levels are available for the Resident Option. The Resident must be able to commit 1 or 2 years within the time frame from approximately June 2024-2026 toward research with level of effort on the proposed research appropriate for the research funding level and the project. It is the responsibility of the PI to select the option that best aligns with their current career path. The option should be selected based on the eligibility defined in the program announcement. It is incumbent upon the early-career investigator to select the suitable option. The critical components of the Career Development Award: · Principal Investigator Fellow Option: The PI must be an early-career researcher or physician-scientist within 7 years after completion of their terminal degree by the time of the application deadline (excluding time spent in residency, clinical training, or on family medical leave). Time spent as a postdoctoral fellow is not excluded. Postdoctoral fellows are not eligible for this award mechanism. The PI’s record of accomplishments and the proposed research will be evaluated regarding their potential to contribute to at least one of the FY23 PRCRP Topic Areas in Section II.A.1. Previous and/or current career development funding outside of institutional startup funds will be taken into consideration when evaluating the need for further developmental funds. The Fellow Option is intended for candidates that have been named on only nominal career development funding. Applications are strongly encouraged to demonstrate protection of the PI’s time for cancer research. For more information on the eligibility criteria for the Fellow Option, refer to Section II.C.1. Resident Option: The PI must be an early-career clinician during the time of their residency. PIs suitable for the Resident Option include investigators interested in a career path toward becoming a physician-scientist. The Resident must articulate a clear plan to accomplish a scientifically rigorous project of either 1 year or 2 years. The PI must demonstrate a commitment to a career as an investigator at the forefront of one of the FY23 PRCRP Topic Areas and clinical practice; however, the PI is not required to have previous cancer research experience. Applications are strongly encouraged to demonstrate protection of the PI’s time for cancer research. Two research funding levels are available for the Resident Option. The Resident must be able to commit 1 or 2 years within the time frame from approximately June 2024-2026 toward research with level of effort on the proposed research appropriate for the research funding level and the project. Resident Research Level 1: A 1-year research project under the guidance of the designated Career Guide must be proposed. The 1-year research project application must include a hypothesis, objectives/aims, and experimental design. Research focused on early hypotheses or conceptual ideas are appropriate for Research Level 1. Resident Research Level 2: A 2-year research project under the guidance of the designated Career Guide must be proposed. The 2-year research project application must be more extensive and include a hypothesis, objectives/aims, an experimental design, and proposed outcomes. Research focused on more developed ideas and hypotheses are appropriate for Research Level 2. The Research Level chosen by the Resident must be justified by the complexity of the research project. It is incumbent upon the early-career investigator to select the suitable research level. · Career Guide: Both the Fellow and the Resident must designate a Career Guide. For the Fellow, the Career Guide must be an experienced cancer researcher, as demonstrated by a strong record of funding and publications. For the Resident, the Career Guide must be an experienced physician-scientist with a strong record of funding and publications in cancer. Under both options, the Career Guide must demonstrate a commitment to advancing the PI’s career in cancer research. · Career Development Plan Fellow Option: A individualized career development plan is required and should be prepared with appropriate guidance from the Career Guide. The career development plan should include a clearly articulated strategy for acquiring the necessary skills, competence, further independence, and expertise to advance their career at the forefront of cancer research in at least one of the FY23 PRCRP Topic Areas. Resident Option: An individualized career development plan is required and should be prepared with appropriate guidance from the Career Guide. The career development plan should include a clearly articulated strategy for acquiring the necessary skills, competence, and expertise that will enable the PI to successfully complete the proposed research project (level 1 or 2) and foster the PI’s development as an independent physician-scientist in at least one of the FY23 PRCRP Topic Areas. An environment appropriate to the proposed mentoring and research project must be clearly described. · Impact: The applicant must articulate the potential impact the proposed work will have on cancer research and/or patient care. Impactful research will accelerate the movement of promising ideas in cancer research into clinical applications. · Preliminary data are not required. Any preliminary data included in the application is subject to evaluation and review. Research proposed should be based on strong scientific reasoning and relevant literature.
Catch-all / unrestricted eligibility mark · HT9425-23-PRCRP-CDA
Grants.gov marks DoD Peer Reviewed Cancer with a catch-all / unrestricted eligibility code (Unrestricted / see official listing). Read the official announcement text for the real applicant filter — the code alone is not a door list. The extract does not mark applicant cost-sharing as required. Instrument: Grant. Funding-activity code maps to Science and Technology / R&D (ST). This eligibility-code string dominates the Defense Health Agency Contracting Activity - DHACA book (1,791 peers, 100% of 1,796).
- Code 99
- Unrestricted / see official listing
Codes are Grants.gov eligibility category values from the extract vintage 2026-08-10. Confirm the full eligibility statement on the official listing or the Grants.gov eligibility reference.
Official Listing on Grants.gov
View full details, application forms, and submission instructions.
Agency Contact
CDMRP Help Desk Phone: 301-682-5507 Email: help@eBRAP.org
More from Defense Health Agency Contracting Activity - DHACA
DoW Neurofibromatosis Synergistic Idea Award
DoW Neurofibromatosis Investigator-Initiated Research Award
DoW Neurofibromatosis Research Academy – Scholar Award
DoW Neurofibromatosis Exploration-Hypothesis Development Award
DOW Combat Readiness – Medical Research Program Translational Research Award
What to do next
DoD Peer Reviewed Cancer is closed; use the parent program and agency catalog for the next funding cycle.
- Browse open federal opportunities in the same category when this listing is closed. Open opportunities
- Look up CFDA 12.420 across all indexed listings before you commit to this opportunity alone. Eligibility finder
- Compare award ranges across federal categories before you pick a single CFDA. All categories
Opportunity deadlines and eligibility change on Grants.gov; PlainGrants mirrors the extract and is not the submission system.
Disclaimer: This information is sourced from Grants.gov and SAM.gov and is for informational purposes only. Opportunity details, deadlines, and eligibility requirements change frequently. Always verify current information directly on Grants.gov before applying. PlainGrants is not affiliated with any federal agency.
Read our methodology - how this data is sourced, computed, and verified.
| Publisher | PlainGrants |
| Sources | the SAM.gov Assistance Listings and Grants.gov |